Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 400

    Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries

    Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries

    Ruby Khatun Khatun27 July 2017 9:14 AM IST
    Holzkirchen: Sandoz announces the expansion of a pilot project with leading charity World Child Cancer, aimed at improving access to treatment and...
    Lupin gets USFDA nod to market solution for skin conditions

    Lupin gets USFDA nod to market solution for skin conditions

    Ruby Khatun Khatun26 July 2017 9:22 AM IST
    New Delhi: Drug firm Lupin on Monday said it has received final approval from the US health regulator to market its Fluocinonide topical solution used...
    Delhi government tells Philip Morris to remove all ads

    Delhi government tells Philip Morris to remove all ads

    Ruby Khatun Khatun26 July 2017 9:20 AM IST
    New Delhi: Delhi government told Philip Morris International Inc and other tobacco companies on Saturday to remove all advertisements from tobacco...
    Merck gets USFDA Tentative Approval for Biologic Insulin

    Merck gets USFDA Tentative Approval for Biologic Insulin

    Ruby Khatun Khatun26 July 2017 9:20 AM IST
    KENILWORTH, N.J.: Merck, known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug Administration(FDA) has granted...
    Pfizer, Merck KGaA skin cancer drug gets EMA nod for approval

    Pfizer, Merck KGaA skin cancer drug gets EMA nod for approval

    Ruby Khatun Khatun26 July 2017 9:19 AM IST
    European regulators on Friday recommended approving Pfizer Inc and Merck KGaA's immuno-oncology drug Bavencio to treat a rare type of skin cancer...
    Amgen And Array BioPharma Announce Preclinical License And Collaboration Agreement In Inflammation

    Amgen And Array BioPharma Announce Preclinical License And Collaboration Agreement In Inflammation

    Ruby Khatun Khatun26 July 2017 9:15 AM IST
    THOUSAND OAKS, Calif. and BOULDER: Amgen and Array BioPharma announced a collaboration agreement for the discovery and development of novel drugs for...
    FDA clears first neonatal magnetic resonance imaging device

    FDA clears first neonatal magnetic resonance imaging device

    Ruby Khatun Khatun25 July 2017 9:35 AM IST
    The U.S. Food and Drug Administration (FDA) cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging...
    GSK receives FDA approval for Benlysta to treat systemic lupus erythematosus

    GSK receives FDA approval for Benlysta to treat systemic lupus erythematosus

    Ruby Khatun Khatun25 July 2017 9:30 AM IST
    London: GSK receives FDA approval for a new self-injectable formulation of Benlysta (belimumab) for systemic lupus erythematosusGSK announced that the...
    Positive disruptions in the pharma world

    Positive disruptions in the pharma world

    Ruby Khatun Khatun25 July 2017 9:22 AM IST
    Mumbai: The Organisation of Pharmaceutical Producers of India (OPPI) held its fifth annual HR summit in the city. The participants were drawn together...
    Strides Shasun gets USFDA nod for anti-allergy capsules

    Strides Shasun gets USFDA nod for anti-allergy capsules

    Ruby Khatun Khatun25 July 2017 9:20 AM IST
    New Delhi: Strides Shasun on Monday said it has received approval from the US Food and Drug Administration for cetirizine hydrochloride capsules, used...
    Merck and Pfizer Collaborate with Corning to Modernize Pharmaceutical Glass Packaging

    Merck and Pfizer Collaborate with Corning to Modernize Pharmaceutical Glass Packaging

    Ruby Khatun Khatun25 July 2017 9:15 AM IST
    CORNING, N.Y.: Merck, Pfizer and Corning Incorporated announced collaborations that have enabled the modernization of pharmaceutical packaging with...
    Janssen gets EU regulatory panels nod for Symtuza to treat HIV

    Janssen gets EU regulatory panel's nod for Symtuza to treat HIV

    Ruby Khatun Khatun24 July 2017 9:30 AM IST
    Beerse, Belgium: Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok